NatureSeptember 3, 2003
The Somatostatin Analogue Octreotide Impairs Sleep and Decreases EEG Sigma Power in Young Male Subjects
Reported by Nature. Read the original →
What the story says
The headline reports that the somatostatin analogue octreotide has an effect on sleep, specifically impairing it, and also decreases EEG sigma power in young male subjects.
Summarised by a model from Nature's headline and its own description of the story. We did not read the article, and this is not our reporting — the link above is.
On file here
Every number below is counted from this library's own approved studies — the ones with a page you can open and check. Counts move as papers are filed.
OctreotideA · Human clinical
- Relationships between increasing pre-load meal size, post-prandial acyl ghrelin, LEAP2, insulin, glucose, appetite, and food intake in adults without obesityHuman · RCT · 2026
- Differential Somatostatin Sensitivity of Corticotropic and Somatotropic Responses Following Amino Acid Infusion.Human · RCT · 2026
- Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.Human · RCT · 1993
What the headline doesn't tell you
- Octreotide has 34 studies on file, 25 of them in humans, the newest published 2026.
Counted, not written: each line is a sentence filled in from the study counts above. None of it is a judgement about the story or the compound.